Flow‐cytometric and quantitative histologic parameters as prognostic indicators for occult retroperitoneal disease in clinical‐stage‐I non‐seminomatous testicular germ‐cell tumors
- 1 June 1994
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 57 (5) , 628-633
- https://doi.org/10.1002/ijc.2910570503
Abstract
Our study was performed to clarify whether the combination of DNA flow-cytometric and quantitative histopathological parameters improves the prediction of occult metastatic disease in clinical stage-I non-seminomatous testicular germ-cell tumors (NSGCT). We used archival paraffin primary-tumor tissue of 67 clinical stage-I NSGCT patients who had undergone retroperitoneal lymph-node dissection (RPLND). According to the RPLND specimens, 24 patients were at pathological stage I and 43 at pathological stage II. Archival blocks were redissected for histological re-evaluation. In addition, 50 μm sections were prepared according to the Hedley technique in order to obtain nuclear suspensions which were processed for flow cytometry (FC). In univariate analysis, the percentage of embryonal carcinoma, the percentage of immature teratoma and vascular invasion were the most accurate predictive histopathological parameters. The percentage of aneuploid cells in S-phase was the best predictive FC parameter. In multivariate analysis, the percentage of embryonal carcinoma and the S-phase fraction of aneuploid cells were the only independent markers for occult metastatic disease. According to this statistical approach, 91.0% of pathological stage-I and stage-II cases were correctly classified. Sensitivity was 95.3% and specificity was 83.3%. Using histopathological criteria alone, only 56.7% NSGCT patients were correctly classified.Keywords
This publication has 17 references indexed in Scilit:
- Primary Retroperitoneal Lymph Node Dissection in Clinical Stage A Non‐seminomatous Germ Cell Testis Cancer Review of the Indiana University Experience 1965–1989British Journal of Urology, 1993
- DNA Ploidy in Testicular Germ Cell Neoplasms Histogenetic and Clinical ImplicationsThe American Journal of Surgical Pathology, 1992
- Prognosis and other clinical correlates of pathologic review in stage I and II testicular carcinoma: a report from the Testicular Cancer Intergroup Study.Journal of Clinical Oncology, 1992
- The Second Medical Research Council study of prognostic factors in nonseminomatous germ cell tumors. Medical Research Council Testicular Tumour Working Party.Journal of Clinical Oncology, 1992
- Comparative evaluation of fresh, fixed, and cryopreserved solid tumor cells for reliable flow cytometry of DNA and tumor associated antigenCytometry, 1992
- Proliferative behaviour and cytogenetic changes in human renal-cell carcinomaWorld Journal of Urology, 1991
- Surveillance for Clinical Stage I Nonseminomatous Testis Carcinoma: Rationale and ResultsUrologia Internationalis, 1991
- Flow cytometry using paraffin‐embedded tissue: Five years onCytometry, 1989
- A Detergent‐trypsin method for the preparation of nuclei for flow cytometric DNA analysisCytometry, 1983
- COMBINED MANAGEMENT OF MALIGNANT TERATOMA OF THE TESTISPublished by Elsevier ,1979